101 related articles for article (PubMed ID: 20408110)
1. Increasing supplemental thyroid hormone use among premature infants born at 23 to 32 weeks' gestation.
Linn M; Yoder BA; Clark RH
Am J Perinatol; 2010 Oct; 27(9):731-5. PubMed ID: 20408110
[TBL] [Abstract][Full Text] [Related]
2. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
van Wassenaer AG; Westera J; Houtzager BA; Kok JH
Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
[TBL] [Abstract][Full Text] [Related]
3. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
4. The influence of amino-acid supplementation, gestational age and time on thyroxine levels in premature neonates.
Kelleher AS; Clark RH; Steinbach M; Chace DH; Spitzer AR;
J Perinatol; 2008 Apr; 28(4):270-4. PubMed ID: 18288119
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?
Van Wassenaer AG; Kok JH; Briët JM; van Baar AL; de Vijlder JJ
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():12-8. PubMed ID: 9439908
[TBL] [Abstract][Full Text] [Related]
6. Trials with thyroid hormone in preterm infants: clinical and neurodevelopmental effects.
van Wassenaer AG; Kok JH
Semin Perinatol; 2008 Dec; 32(6):423-30. PubMed ID: 19007681
[TBL] [Abstract][Full Text] [Related]
7. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes.
Woo HC; Lizarda A; Tucker R; Mitchell ML; Vohr B; Oh W; Phornphutkul C
J Pediatr; 2011 Apr; 158(4):538-42. PubMed ID: 21232766
[TBL] [Abstract][Full Text] [Related]
8. Repeat testing for congenital hypothyroidism in preterm infants is unnecessary with an appropriate thyroid stimulating hormone threshold.
Korada M; Pearce MS; Ward Platt MP; Avis E; Turner S; Wastell H; Cheetham T
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F286-8. PubMed ID: 18252816
[TBL] [Abstract][Full Text] [Related]
9. Developmental follow-up of very low birthweight premature infants with low free thyroxine.
Karna P
Am J Perinatol; 1991 Jul; 8(4):288-91. PubMed ID: 1741876
[TBL] [Abstract][Full Text] [Related]
10. Early death, morbidity, and need of treatment among extremely premature infants.
Markestad T; Kaaresen PI; Rønnestad A; Reigstad H; Lossius K; Medbø S; Zanussi G; Engelund IE; Skjaerven R; Irgens LM;
Pediatrics; 2005 May; 115(5):1289-98. PubMed ID: 15867037
[TBL] [Abstract][Full Text] [Related]
11. The limit of viability--neonatal outcome of infants born at 22 to 25 weeks' gestation.
Allen MC; Donohue PK; Dusman AE
N Engl J Med; 1993 Nov; 329(22):1597-601. PubMed ID: 8179651
[TBL] [Abstract][Full Text] [Related]
12. [Morbidity and mortality of extremely low gestational age infants in Schleswig-Holstein. Follow-up at three to six years corrected age of infants < 27 + 0 weeks gestation in Schleswig-Holstein, Germany].
Rapp M; Thyen U; Müller-Steinhardt K; Kohl M
Z Geburtshilfe Neonatol; 2005 Aug; 209(4):135-43. PubMed ID: 16138271
[TBL] [Abstract][Full Text] [Related]
13. Hypothyroxinemia of prematurity: rite of passage or therapeutic necessity?
Beeram MR; Wilson DP
Tex Med; 2000 Nov; 96(11):60-3. PubMed ID: 11125989
[TBL] [Abstract][Full Text] [Related]
14. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
[TBL] [Abstract][Full Text] [Related]
15. Establishment of hormone reference intervals for infants born < 30 weeks' gestation.
Greaves RF; Zacharin MR; Donath SM; Inder TE; Doyle LW; Hunt RW
Clin Biochem; 2014 Oct; 47(15):101-8. PubMed ID: 24927648
[TBL] [Abstract][Full Text] [Related]
16. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.
Stevens TP; Sinkin RA; Hall CB; Maniscalco WM; McConnochie KM
Arch Pediatr Adolesc Med; 2000 Jan; 154(1):55-61. PubMed ID: 10632251
[TBL] [Abstract][Full Text] [Related]
18. Improving head growth in preterm infants--a randomised controlled trial II: MRI and developmental outcomes in the first year.
Tan M; Abernethy L; Cooke R
Arch Dis Child Fetal Neonatal Ed; 2008 Sep; 93(5):F342-6. PubMed ID: 18285378
[TBL] [Abstract][Full Text] [Related]
19. Thyroxine for transient hypothyroxinemia and cerebral palsy in extremely preterm infants.
Suzumura H; Nitta A; Tsuboi Y; Watabe Y; Kuribayashi R; Arisaka O
Pediatr Int; 2011 Aug; 53(4):463-7. PubMed ID: 21054676
[TBL] [Abstract][Full Text] [Related]
20. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
